Try our Advanced Search for more refined results

MultiVir Eyes Float Amid Stream Of Cancer-Focused IPOs

By Chelsea Naso ( March 30, 2015, 1:49 PM EDT) -- Texas-based MultiVir Inc., which is developing gene therapies to treat cancer, outlined plans Monday to launch an initial public offering on the Nasdaq, just days after cancer immunotherapy developer Cellectis SA priced an upsized IPO and a handful of other cancer-focused companies have seen their share prices more than double....

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login

Related Sections

Law Firms

Companies

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!